-
Mashup Score: 4Video Conferencing, Web Conferencing, Webinars, Screen Sharing - 1 year(s) ago
Zoom is the leader in modern enterprise video communications, with an easy, reliable cloud platform for video and audio conferencing, chat, and webinars across mobile, desktop, and room systems. Zoom Rooms is the original software-based conference room solution used around the world in board, conference, huddle, and training rooms, as well as executive offices and classrooms. Founded in 2011,…
Source: ZoomCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
“Overall, having a larger database of project knowledge is always useful even if there are some gaps that can be evaluated.” Marc Better, Pharmefex https://t.co/0lDOfssgCr #CellTherapies #CGTFriends https://t.co/9YOESEOOFZ
-
Starting now! Virtual #cell therapies meeting panel discussion moderated by Michael Kalos, Next Pillar Consulting. https://t.co/0lDOfssgCr #CellTherapies #CGTFriends https://t.co/7KnyEpvBiR
-
first time in human steps and ultimately resulted in a successful program which was able to deliver a treatment to patients sooner.” Jonathan Jazayeria, @KitePharma https://t.co/0lDOfssgCr #CellTherapies #CGTFriends
-
-
Mashup Score: 0The Next Generation of Cellular Therapies: Opportunities to Accelerate Development - Friends of Cancer Research - 1 year(s) ago
1800 M Street NW, Suite 1050 South,Washington, DC 20036Phone: (202) 944-6700Friends of Cancer Research is a 501 (C)(3) non-profit organization.Our tax ID number is 52-1983273. About Careers Contact Donate Privacy Policy Policy on Corporate Partnerships Terms &…
Source: Friends of Cancer ResearchCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Starting soon! @CancerResrch virtual #cell therapies meeting 12 – 1 PM EST. Click to register: https://t.co/hQxr1OTjPA #CellTherapies #CGTFriends
-
-
Mashup Score: 0Join our Cloud HD Video Meeting - 1 year(s) ago
Zoom is the leader in modern enterprise video communications, with an easy, reliable cloud platform for video and audio conferencing, chat, and webinars across mobile, desktop, and room systems. Zoom Rooms is the original software-based conference room solution used around the world in board, conference, huddle, and training rooms, as well as executive offices and classrooms. Founded in 2011,…
Source: Zoom VideoCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
“The goal here is to find a balance. We are looking at a long term follow up versus a short-term duration. We have more data being generated but is it informative?” Julie Jadlowsky, @Penn https://t.co/0lDOfssgCr #CellTherapies #CGTFriends https://t.co/vBzEKdLzE8
-
Starting now! Presentation 1: Academic Institution Experience with Julie Jadlowsky, @Penn https://t.co/0lDOfssgCr #CellTherapies #CGTFriends https://t.co/f7BYwKORIf
-
“I think there is a lot of excitement here in part because once you can make multiple genome edits into these cells you can potentially have more complex constructs in an allogeneic package.” @FDACBER's Director Peter Marks. https://t.co/0lDOfssgCr https://t.co/xbVIzwSXSe
-
“Last year we had close to 100 submissions of CAR-T cells in various applications.” @FDACBER's Director Peter Marks live @CancerResrch’s virtual #cell therapies meeting. https://t.co/0lDOfssgCr #CellTherapies #CGTFriends https://t.co/PHjzKim9Zx
-
Click to watch @FDACBER's Director Peter Marks live @CancerResrch’s virtual #cell therapies meeting. https://t.co/0lDOfssgCr #CellTherapies #CGTFriends https://t.co/5bsHaRIC8X
-
-
Mashup Score: 0The Next Generation of Cellular Therapies: Opportunities to Accelerate Development - Friends of Cancer Research - 1 year(s) ago
1800 M Street NW, Suite 1050 South,Washington, DC 20036Phone: (202) 944-6700Friends of Cancer Research is a 501 (C)(3) non-profit organization.Our tax ID number is 52-1983273. About Careers Contact Donate Privacy Policy Policy on Corporate Partnerships Terms &…
Source: Friends of Cancer ResearchCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Today! @CancerResrch virtual #cell therapies meeting 12 – 1 PM EST featuring @FDACBER's Director Peter Marks. Click to register: https://t.co/hQxr1OTjPA #CellTherapies #CGTFriends https://t.co/r0jTU6avne
-
-
Mashup Score: 0The Next Generation of Cellular Therapies: Opportunities to Accelerate Development - Friends of Cancer Research - 1 year(s) ago
1800 M Street NW, Suite 1050 South,Washington, DC 20036Phone: (202) 944-6700Friends of Cancer Research is a 501 (C)(3) non-profit organization.Our tax ID number is 52-1983273. About Careers Contact Donate Privacy Policy Policy on Corporate Partnerships Terms &…
Source: Friends of Cancer ResearchCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Only a day away! @CancerResrch virtual #cell therapies meeting on March 8 from 12 – 1 PM EST. Click to register: https://t.co/hQxr1OTjPA #CellTherapies #CGTFriends
-
-
Mashup Score: 2AI analyses cell movement under the microscope - 1 year(s) ago
Using artificial intelligence (AI), researchers at the University of Gothenburg can now follow cell movement across time and space. The method could be very helpful for developing more effective cancer medications.
Source: EurekAlert!Categories: General Medicine News, Latest HeadlinesTweet-
Using artificial intelligence (#AI), researchers at @goteborgsuni can now follow #cell movement across time and space; The method could be very helpful for developing more effective #cancer #medications https://t.co/Oa4P4uY6f8
-
-
Mashup Score: 0Patient-Derived Xenograft and Cell Line Models of Human Primary Cutaneous Diffuse Large B-Cell Lymphoma-Leg Type - 1 year(s) ago
Primary cutaneous diffuse large B-cell lymphoma, leg-type (PCDLBCL-LT) is a rare and aggressive malignancy, mostly occurring on the leg of elderly women (Willemze et al., 2019). PCDLBCL-LT harbors an activated B-cell‒like diffuse large B-cell lymphoma (ABC-DLBCL) signature and is enriched for mutations involving the toll-like receptor, B-cell receptor, and NF-κB pathways (Pham-Ledard et al.,…
Categories: Dermatology, Latest HeadlinesTweet-
2/2 This may facilitate deciphering the mechanism of PCDLBCL-LT and drug screening #PDX #ARSI https://t.co/I2llKdZKZl https://t.co/THC5oGoJsj
-
1/2 Bresson-Bepoldin and co-authors report the successful expansion of cutaneous B lymphoma cells followed by the establishment of a primary cutaneous diffuse large B-cell lymphoma, leg-type (PCDLBCL-LT) #cell line. https://t.co/I2llKdZKZl https://t.co/L8z1gkRTRx
-
-
Mashup Score: 0
Skip Nav Destination January 26, 2023 In patients with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), the use of the oral PI3Kδ inhibitor leniolisib reduced lymphadenopathy and normalized immune cell subsets,…
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
#Leniolisib was found to improve markers of immune dysregulation and deficiency in patients with activated PI3Kδ syndrome (#APDS), reducing #lymphadenopathy and normalizing #immune #cell subsets https://t.co/r9VJdnIqXV
-
-
Mashup Score: 1
Objectives Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are age-associated inflammatory diseases that frequently overlap. Both diseases require long-term treatment with glucocorticoids (GCs), often associated with comorbidities. Previous population-based cohort studies reported that an unhealthier metabolic profile might prevent the development of GCA. Here, we report metabolic…
Source: RMD OpenCategories: Latest Headlines, RheumatologyTweet-
Interested in #giant #cell #arteritis? Check out our latest publication on #glucocorticoid treatment: ▶️ patients at onset showed a dysregulated lipid and glucose metabolism ▶️ glucocorticoid treatment related to increased risk of comorbidities 🔗 https://t.co/pTkPcI6UAx https://t.co/gxXVAzBcTp
-
-
Mashup Score: 0HU May Lower Malaria Incidence in Children With Sickle Cell Anemia | ASH Clinical News | American Society of Hematology - 1 year(s) ago
Skip Nav Destination January 18, 2023 In children with sickle cell anemia in Africa, the maximum tolerated dose (MTD) of hydroxyurea (HU) is associated with a lower incidence of malaria, according to study results published in…
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
In children with #sickle #cell #anemia in Africa, the maximum tolerated dose of #hydroxyurea is associated with a lower incidence of #malaria, according to study findings published in @BloodJournal https://t.co/9ANzvWwulx
-
and discuss with the @US_FDA opportunities for data extrapolation so we can do this for more programs.” Jonathan Jazayeria, @KitePharma https://t.co/0lDOfssgCr #CellTherapies #CGTFriends